Alkermes Plc (ALKS)
28.00
+0.24
(+0.86%)
USD |
NASDAQ |
Mar 16, 16:00
27.90
-0.10
(-0.36%)
After-Hours: 06:42
Alkermes Market Cap : 4.666B for March 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Krystal Biotech, Inc. | 7.313B |
| Avadel Pharmaceuticals Plc | 2.124B |
| Assertio Holdings, Inc. | 75.53M |
| Amarin Corp. Plc | 320.80M |
| Amicus Therapeutics, Inc. | 4.512B |
Market Cap Related Metrics
| PE Ratio | 19.55 |
| PS Ratio | 3.202 |
| Price to Book Value | 2.565 |
| Price to Free Cash Flow | 9.839 |
| Price | 28.00 |
| Earnings Yield | 5.12% |
| Operating PE Ratio | 18.61 |
| Normalized PE Ratio | 19.54 |